LRI Investments LLC Sells 93 Shares of HCA Healthcare, Inc. $HCA

LRI Investments LLC lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 53.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81 shares of the company’s stock after selling 93 shares during the quarter. LRI Investments LLC’s holdings in HCA Healthcare were worth $31,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth about $1,021,000. Farther Finance Advisors LLC raised its stake in shares of HCA Healthcare by 26.9% in the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock worth $395,000 after purchasing an additional 242 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of HCA Healthcare by 17.6% in the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock worth $1,704,000 after purchasing an additional 737 shares during the last quarter. Stock Yards Bank & Trust Co. purchased a new position in shares of HCA Healthcare in the first quarter worth about $394,000. Finally, Ritholtz Wealth Management raised its stake in shares of HCA Healthcare by 19.4% in the first quarter. Ritholtz Wealth Management now owns 8,992 shares of the company’s stock worth $3,107,000 after purchasing an additional 1,462 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

NYSE HCA opened at $410.71 on Tuesday. The stock’s fifty day moving average is $406.07 and its two-hundred day moving average is $376.56. The firm has a market capitalization of $96.10 billion, a P/E ratio of 17.26, a price-to-earnings-growth ratio of 1.31 and a beta of 1.40. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $439.01.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the previous year, the company posted $5.50 earnings per share. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were given a $0.72 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s payout ratio is currently 12.11%.

Analysts Set New Price Targets

HCA has been the topic of several analyst reports. Royal Bank Of Canada dropped their target price on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a report on Monday, July 28th. Wells Fargo & Company raised their target price on HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 7th. Bank of America raised their target price on HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a report on Wednesday, September 10th. Truist Financial raised their target price on HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a report on Wednesday, July 16th. Finally, Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $422.31.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.